CAN logo

Cann Group Stock Price

Symbol: ASX:CANMarket Cap: AU$9.1mCategory: Pharmaceuticals & Biotech

CAN Share Price Performance

AU$0.014
-0.02 (-62.16%)
AU$0.014
-0.02 (-62.16%)
Price AU$0.014

CAN Community Narratives

There are no narratives available yet.

CAN Community Fair Values

    Recent CAN News & Updates

    No updates

    Cann Group Limited Key Details

    AU$15.5m

    Revenue

    AU$10.6m

    Cost of Revenue

    AU$4.9m

    Gross Profit

    AU$52.5m

    Other Expenses

    -AU$47.6m

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.073
    Gross Margin
    31.76%
    Net Profit Margin
    -306.99%
    Debt/Equity Ratio
    1,136.9%

    Cann Group Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About CAN

    Founded
    2014
    Employees
    n/a
    CEO
    Jennifer Pilcher
    WebsiteView website
    www.canngrouplimited.com

    Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

    Australian Market Performance

    • 7 Days: -0.4%
    • 3 Months: 6.8%
    • 1 Year: 13.2%
    • Year to Date: 5.2%
    The market has stayed flat over the 7 days. Meanwhile, the market is actually up 13% over the past year. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading